Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/6/2025

Midazolam-Induced Hypotension

Patient Population and Dosing

  • The American Gastroenterological Association recommends that elderly patients (≥60 years) require a dose reduction of 20% or more when administered midazolam, with an initial IV dose of 1-2 mg maximum (or ≤0.03 mg/kg) injected over 1-2 minutes 1, 2
  • The American Gastroenterological Association suggests that the initial dose for high-risk adult patients (Age ≥60, ASA ≥3, cardiovascular disease) should be 1 mg maximum, with a dose reduction of 20% or more from standard dosing 1, 2
  • The European Society for Medical Oncology recommends that when midazolam is combined with opioids, a synergistic interaction occurs requiring dose reduction, with a recommended dose of 0.5-1 mg SC/IV q1h PRN (maximum 2.5-5 mg) 3

Monitoring and Administration

  • The European Society of Cardiology recommends that blood pressure monitoring is essential during and after midazolam administration 4
  • The American Gastroenterological Association suggests that rapid IV administration of midazolam should be avoided, as it can cause more severe hypotension, and that the drug should always be injected over 1-2 minutes 1, 2

Drug Interactions

  • The American Gastroenterological Association warns that combining midazolam with opioids without dose adjustment can lead to synergistic effects that dramatically increase hypotension and respiratory depression risk 1, 2, 3